ESC 365 - Spironolactone treatment does not cause significant hyperkalemia at patients hospitalized because of chronic or acute heart failure - a meta-analysis

HFA Premium Access

Spironolactone treatment does not cause significant hyperkalemia at patients hospitalized because of chronic or acute heart failure - a meta-analysis

Session: Poster Session 4 - Acute Heart Failure– Treatment

Topic: Pharmacotherapy

Speaker: Ms J. Wagner (Pecs, HU)

Event: Heart Failure 2018

Congress Presentation

Add to my library

About the speaker

Ms Juliane Wagner

University of Pecs, Pecs (Hungary)

0 follower

5 more presentations in this session

Acute heart failure un the elderly: which is the treatment of choice at discharge? Real world data from the ATHENA registry

Speaker: Doctor A. Lo Forte (Messina, IT)

Pulmonary congestion, VA-ECMO output and outcome after cardiac surgery

Speaker: Associate Professor W. Speidl (Vienna, AT)

Refractory cardiogenic shock: emergency mechanical circulatory support as a bridge to recovery

Speaker: Doctor N. Piatrovich (Minsk, BY)

Comparison of the effectiveness of transcatheter aortic valve implantation in patients with pure aortic valve regurgitation versus aortic stenosis

Speaker: Doctor E. Munoz Garcia (Malaga, ES)

It is difficult to be first in class - Suitability of heart failure admission patients for ARNI

Access the full session

Poster Session 4 - Acute Heart Failure– Treatment

Speakers: Ms J. Wagner, Doctor A. Lo Forte, Associate Professor W. Speidl, Doctor N. Piatrovich, Doctor E. Munoz Garcia

About the event

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources